The Importance of Testing PET-Directed Therapy in Patients with Hodgkin Lymphoma

被引：0
|
作者：
James O. Armitage
机构：
[1] University of Nebraska Medical Center,The Joe Shapiro Professor of Medicine, Department of Internal Medicine
来源：
Current Hematologic Malignancy Reports | 2011年 / 6卷
关键词：
Bleomycin; Hodgkin Lymphoma; Dacarbazine; Procarbazine; Classic Hodgkin Lymphoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Measuring the rapidity of response by PET scan and changing the treatment regimen in slow responders may lead to an improved outcome. Ongoing studies addressing this possibility have the potential to answer this question and need to be supported.
引用
收藏
页码：155 / 156
页数：1
相关论文
共 50 条
  • [31] Experimental therapy for Hodgkin's lymphoma patients
    Boell, B.
    Borchmann, P.
    Engert, A.
    ONKOLOGE, 2010, 16 (01): : 48 - +
  • [32] Vocal Emotion in Pet-Directed and Infant-Directed Speech: Similar Sounds and Functions, but Different Determinants
    Burnham, Denis
    Opacic, Michelle
    Vollmer-Conna, Ute
    ANTHROZOOS, 2024, 37 (04): : 791 - 810
  • [33] Early therapy monitoring with FDG-PET in aggressive non-Hodgkin’s lymphoma and Hodgkin’s lymphoma
    Tatsuo Torizuka
    Fumitoshi Nakamura
    Toshihiko Kanno
    Masami Futatsubashi
    Etsuji Yoshikawa
    Hiroyuki Okada
    Masahide Kobayashi
    Yasuomi Ouchi
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 22 - 28
  • [34] Early therapy monitoring with FDG PET in aggressive Hodgkin's lymphoma
    Biggi, A
    Peano, S
    Bianchi, A
    Gallamini, A
    Calvi, R
    Castagnoli, A
    Rigacci, L
    Levis, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S336 - S336
  • [35] "Pet Negativity"-The New Goal of Cytoreductive Therapy in Hodgkin's Lymphoma?
    Sweetenham, John W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (11) : 1569 - 1570
  • [36] PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma reply
    Casasnovas, Rene-Olivier
    Bouabdallah, Reda
    Brice, Pauline
    Lazarovici, Julien
    Ghesquieres, Herve
    Stamatoullas, Aspasia
    Berriolo-Riedinger, Alina
    Fornecker, Luc-Matthieu
    Andre, Marc
    Meignan, Michel
    LANCET ONCOLOGY, 2019, 20 (04): : E190 - E190
  • [37] Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma
    Kluge, R.
    Koerholz, D.
    KLINISCHE PADIATRIE, 2011, 223 (06): : 315 - 319
  • [38] PET-adapted approaches to primary therapy for advanced Hodgkin lymphoma
    Lang, Noemie
    Crump, Michael
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [39] Pet findings in lungs in patients treated for Hodgkin's lymphoma
    Mocikova, H
    Markova, J
    Belohlavek, O
    ANNALS OF ONCOLOGY, 2005, 16 : 120 - 120
  • [40] PET/CT SURVEILLANCE IN PATIENTS WITH HODGKIN LYMPHOMA IN FIRST REMISSION
    El-Galaly, T. C.
    Hutchings, M.
    Bukh, A.
    Iyer, V.
    Boegsted, M.
    Johnsen, H.
    Christiansen, I.
    ANNALS OF ONCOLOGY, 2011, 22 : 160 - 160
12345